Valink Therapeutics
PrivateLast Round
Seed
Oct 20, 2025
Est. Valuation
$1.79M
Total Funding Raised
$19.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Valink Therapeutics is a biotechnology company that develops next-generation, antibody-based therapeutics, specifically bispecific antibody-drug conjugates (bsADCs), to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valink Therapeutics Comparables
Compare Valink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Archon Biosciences | 81% | |
| Arpelos Biosciences | 80% | |
| Fortitude Biomedicines | 76% |
Valink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2025 | ||||
| Seed | Nov 2, 2023 | ||||
| Accelerator | Mar 24, 2021 | ||||
| Accelerator | Jan 1, 2021 |
Key People
Founding team and executive leadership
Valink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Magnet Ventures | Seed |
| Metaplanet Holdings | Seed |
| Oxford Science Enterprises | Seed |
| Acequia Capital | Seed |
| Hoxton Ventures | Seed |
| Oxonian Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 1498% MoM, reaching 1.8K.
- Dec 17, 2025
Partnered with Nona Biosciences for integrated drug discovery solutions.
Valink Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Valink Therapeutics's valuation, stock price, and market status.
Is Valink Therapeutics a public or private company?
Valink Therapeutics is a private company.
What is the current stock price of Valink Therapeutics?
Valink Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Valink Therapeutics worth (valuation)?
Valink Therapeutics's valuation is estimated at $1.8M based on funding round data.
Can I buy Valink Therapeutics stock?
Valink Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Valink Therapeutics's last funding round?
Valink Therapeutics's most recent funding round was Early Funding on March 24, 2021.
Who are the main investors in Valink Therapeutics?
Key investors in Valink Therapeutics include Y Combinator, RV Invest, Redalpine.
Will Valink Therapeutics IPO soon?
No public IPO plans have been announced for Valink Therapeutics.
How can I track Valink Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Valink Therapeutics's secondary market activity and sign up for updates.